RG

Ravi Gupta

Active Director Director DIN 09399651
DIN 09399651 First appointment Nov 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravi Gupta

Data last updated:

Ravi Gupta is a Director at Panaceacure Medicine Private Limited (since 2021). The company operates in Chemicals.

DIN 09399651
Primary Designation Director
Industry Chemicals
First Appointment 15 Nov 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Panaceacure Medicine Private Limited U24230UP2021PTC155456
Director15 Nov 20212021Active

Board colleagues of Ravi Gupta

NameDINCompanyDesignation
Rajesh Kumar09399652Panaceacure Medicine Private LimitedDirector

Directorship timeline

Open interactive timeline →
Panaceacure Medicine Private Limited
Premium access

Shareholding and investment profile for Ravi Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Gupta

Ravi Gupta currently holds 1 directorship: Panaceacure Medicine Private Limited (Director, since 15 Nov 2021).

Ravi Gupta was first appointed on 15 Nov 2021 as Director at Panaceacure Medicine Private Limited.

The current boards of Ravi Gupta's companies include Rajesh Kumar (Panaceacure Medicine Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available